Education
About Us
Working with TipRanks
Follow Us
Theralink Technologies (THER)
OTHER OTC:THER
THER Stock Chart & Stats
$0.02
$0.00(0.00%)
At close: 4:00 PM EST
$0.02
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume10.00
Average Volume (3M)N/A
Market Cap
$6.15K
Enterprise Value$19.38M
Total Cash (Recent Filing)$998.28K
Total Debt (Recent Filing)$19.76M
Price to Earnings (P/E)―
Beta-58.96
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding6,151,500,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.09
P/FCF Ratio>-0.01
Enterprise Value/Market Cap3.15K
Enterprise Value/Revenue25.70
Enterprise Value/Gross Profit32.93
Enterprise Value/Ebitda-2.47
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
THER FAQ
What was Theralink Technologies’s price range in the past 12 months?
Theralink Technologies lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Theralink Technologies’s market cap?
Theralink Technologies’s market cap is $6.15K.
When is Theralink Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Theralink Technologies’s earnings last quarter?
Currently, no data Available
Is Theralink Technologies overvalued?
According to Wall Street analysts Theralink Technologies’s price is currently Overvalued.
Does Theralink Technologies pay dividends?
Theralink Technologies does not currently pay dividends.
What is Theralink Technologies’s EPS estimate?
Theralink Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theralink Technologies have?
Theralink Technologies has 6,151,500,000 shares outstanding.
What happened to Theralink Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Theralink Technologies?
Currently, no hedge funds are holding shares in THER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Theralink Technologies
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.
Technical Analysis
Scinai Immunotherapeutics
―
NewcelX
―
Dermata Therapeutics
―
CDT Equity
―
Virax Biolabs Group Ltd. Class A
―